Eikon Therapeutics Q3 EPS $(1.59) Beats $(1.68) Estimate
Benzinga Newsdesk 1 hour ago
NewsEarningsEarnings Beats
Eikon Therapeutics (NASDAQ:EIKN) reported quarterly losses of $(1.59) per share which beat the analyst consensus estimate of $(1.68) by 5.36 percent. This is a 93.44 percent increase over losses of $(24.24) per share
Eikon Therapeutics (NASDAQ:EIKN) reported quarterly losses of $(1.59) per share which beat the analyst consensus estimate of $(1.68) by 5.36 percent. This is a 93.44 percent increase over losses of $(24.24) per share from the same period last year.